Allen Richard M, Mandt Bruce H, Jaskunas Jillian, Hackley Amanda, Shickedanz Alyssa, Bergkamp David
Department of Psychology, University of Colorado Denver, 1200 Larimer Street, Denver, CO 80204, United States.
Department of Psychology, University of Colorado Denver, 1200 Larimer Street, Denver, CO 80204, United States.
Drug Alcohol Depend. 2015 Feb 1;147:137-43. doi: 10.1016/j.drugalcdep.2014.11.027. Epub 2014 Dec 9.
Blocking N-methyl-d-aspartate (NMDA) glutamate receptors (NMDARs) prevents cocaine locomotor sensitization, but facilitates escalation of cocaine self-administration and produces ambiguous effects on acquisition of cocaine self-administration. This study used a recently described model of acquisition and escalation to test the hypothesis that continuous NMDAR antagonism functionally increases the effects of a given dose of cocaine.
We assessed acquisition of cocaine self-administration (0.6 mg/kg/infusion) in rats treated continuously with either vehicle or the NMDAR antagonist dizocilpine (0.4 mg/kg/day) for 14 consecutive 2h fixed ratio 1 (FR1) sessions. In a separate experiment that assessed the effect of dizocilpine treatment on escalation of cocaine self-administration, rats acquired cocaine self-administration (0.6 mg/kg/infusion) prior to vehicle or dizocilpine treatment. Then, immediately post-acquisition, rats were treated continuously with either vehicle or dizocilpine and allowed to self-administer either 0.6 or 1.2mg/kg/infusion cocaine for an additional seven consecutive 2h FR1 sessions.
Relative to vehicle-treated rats, a significantly greater percentage of dizocilpine-treated rats acquired cocaine self-administration. During the escalation experiment, both vehicle- and dizocilpine-treated rats escalated intake of 1.2mg/kg/infusion cocaine. Whereas vehicle-treated rats exhibited stable intake of 0.6 mg/kg/infusion cocaine, dizocilpine-treated rats escalated intake of this moderate cocaine dose to levels indistinguishable from intake levels produced by self-administration of the high cocaine dose (i.e., 1.2mg/kg/infusion).
These findings suggest that chronic NMDAR blockade potentiates, rather than attenuates, cocaine's effects and argue for reconsideration of the role of NMDARs in cocaine "addiction-like" behavior.
阻断N-甲基-D-天冬氨酸(NMDA)谷氨酸受体(NMDARs)可预防可卡因运动致敏,但会促进可卡因自我给药行为的升级,并且对可卡因自我给药行为的习得产生不明确的影响。本研究使用了一种最近描述的习得和升级模型,以检验持续的NMDAR拮抗作用在功能上会增强给定剂量可卡因效果的假设。
我们评估了连续14个2小时固定比率1(FR1)时段内,持续接受溶剂或NMDAR拮抗剂地佐环平(0.4mg/kg/天)治疗的大鼠对可卡因自我给药(0.6mg/kg/输注)的习得情况。在一项单独的评估地佐环平治疗对可卡因自我给药行为升级影响的实验中,大鼠在接受溶剂或地佐环平治疗之前先习得可卡因自我给药(0.6mg/kg/输注)。然后,在习得后立即,大鼠持续接受溶剂或地佐环平治疗,并允许其连续7个2小时的FR1时段内自我给药0.6或1.2mg/kg/输注的可卡因。
相对于接受溶剂治疗的大鼠,接受地佐环平治疗的大鼠中习得可卡因自我给药的比例显著更高。在升级实验中,接受溶剂和地佐环平治疗的大鼠都增加了1.2mg/kg/输注可卡因的摄入量。接受溶剂治疗的大鼠对0.6mg/kg/输注可卡因的摄入量保持稳定,而接受地佐环平治疗的大鼠将这种中等剂量可卡因的摄入量增加到与高剂量可卡因(即1.2mg/kg/输注)自我给药产生的摄入量水平无法区分的程度。
这些发现表明,慢性NMDAR阻断增强而非减弱了可卡因的作用,并支持重新考虑NMDARs在可卡因“成瘾样”行为中的作用。